logo-loader

OptiBiotix Health signs a sweet deal with US manufacturer to produce a line of SweetBiotix

Published: 23:37 16 Sep 2020 AEST

OptiBiotix Health PLC's (LON:OPTI) Stephen O'Hara talks to Proactive London about their deal with an unnamed US company to manufacture and commercialise a line of its SweetBiotix.

The new partner has been granted an exclusive worldwide licence for the natural alternatives to sugar. In return, it will take on manufacturing and marketing costs of the roll-out and all future expenditure for a number of products.

The identity of the new partner is being kept confidential to protect its launch plans.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

5 hours, 39 minutes ago